Company · CIK 0001042418 · SIC 2834 — Pharmaceutical Preparations · OTC
Inhibitor Therapeutics, Inc. · INTI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 GForm 4 → | Aug 4, 9:03 pm EDT | Black Robe Capital LLC +110% Owner | 3,200,000 | — | — | 19,901,057 | — | late |
| May 4, 2026 AForm 4 → | Aug 4, 1:33 pm EDT | Ronald E Osman +1Director, 10% Owner | 50,000 | — | — | 23,614,985 | — | late |
| May 4, 2026 AForm 4 → | Aug 4, 12:19 pm EDT | Michelle YanezDirector | 50,000 | — | — | 1,221,271 | — | late |
| May 4, 2026 AForm 4 → | Aug 4, 12:15 pm EDT | Samuel P Sears Jr.Director | 50,000 | — | — | 1,229,543 | — | late |
| May 4, 2026 AForm 4 → | Aug 4, 11:55 am EDT | Francis E Odonnell Jr.Chief Executive Officer, Director, 10% Owner | 50,000 | — | — | 150,000 | — | late |
| May 4, 2026 AForm 4 → | Jun 24, 12:34 pm EDT | Michael Allen JermanDirector | 50,000 | — | — | 180,411 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.